Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA

Links shared publicly online about this topic.

  • 303
    total visits

Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA

oncologynurseadvisor.com

Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).

View full resource at oncologynurseadvisor.com

Tags: IBD, Crohn's Disease Medication, Ulcerative Colitis, Ulcerative Colitis Medication, Rheumatoid Arthritis Medication, Phase 3 Clinical Trial, Remicade, Ulcer

  • Share

Most Recently Shared on May 10, 2011 at 3:36 pm By:

ONAcom OncologyNurseAdvisor

Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients http://goo.gl/fb/qYVQj

1 year ago...

New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis

jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.View full resource at jnj.com

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 7:22 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

New Phase 3 Study Results 4 REMICADE® in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis - http://ow.ly/4RvIc

1 year ago...

Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR

empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 3:54 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c

1 year ago...

New Phase 3 Study Results Show Remicade Is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis - Drugs.com MedNews

drugs.com — “Study Findings Demonstrate Clinical Response with REMICADE in Pediatric Patients Who Have Not Responded to Conventional Therapy Chicago, IL, May 9, 2011 - DataView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 2:12 pm By:

Drugs_Devices Drugs and Devices OW OW Health

New Phase 3 Study Results Show Remicade Is Effective in the Treatment of Pediatric Patients With Moderate ... http://bit.ly/kusZrR #drug

1 year ago...

Advertisement